Literature DB >> 10803661

Distribution of the 3' VNTR polymorphism in the human dopamine transporter gene in world populations.

R J Mitchell1, S Howlett, L Earl, N G White, J McComb, M S Schanfield, I Briceno, S S Papiha, L Osipova, G Livshits, W R Leonard, M H Crawford.   

Abstract

A polymorphism with a variable number of tandem repeats (VNTR) found in the 3' untranslated region of the human dopamine transporter gene (DAT1) was scored in unrelated individuals drawn from 10 geographically widely dispersed populations in order to assess this marker's usefulness in human population genetics. The populations that were analyzed in this study included 4 indigenous groups of Siberia, natives of North and South America, as well as Caucasian and Oceanic groups, most of which represented small-scale societies. A total of 5 DAT1 alleles were seen overall, but only in one Siberian population, the Altai-Kizhi, were all 5 present, and in the Native Americans of Colombia the locus was monomorphic. The most common allele, DAT1*10, ranged in frequency from 52% in Greeks to 100% in South Americans. The high frequency of the DAT1*10 allele (approximately 90%) among Mongoloid groups of north and east Asia distinguishes them from most Caucasian groups. The presence of the rare DAT1*7 allele in relatively high frequency (approximately 5%) among all Siberian groups suggests a close affinity with north Asian groups, especially Mongolians. The presence of the even rarer DAT1*13 allele in one Siberian population, the Altai-Kizhi, reflects this group's long historical contact with Mongolians. The results demonstrated that the DAT1 VNTR polymorphism is useful in investigating population relationships, and that rare alleles at this locus may be particularly valuable in understanding the extent of genetic affinity between neighboring groups and in situations where admixture is suspected. However, because of both the association and linkage of this VNTR locus with attention-deficit hyperactivity disorder (ADHD) in children, and its highly restricted polymorphism (usually 3 alleles) in most human groups, the possibility of selection constraints on the DAT1 gene cannot be ignored.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10803661

Source DB:  PubMed          Journal:  Hum Biol        ISSN: 0018-7143            Impact factor:   0.553


  42 in total

Review 1.  Genes and attention deficit hyperactivity disorder.

Authors:  J Swanson; M Posner; J Fusella; M Wasdell; T Sommer; J Fan
Journal:  Curr Psychiatry Rep       Date:  2001-04       Impact factor: 5.285

2.  Genetic influences of dopamine transport gene on alcohol dependence: a pooled analysis of 13 studies with 2483 cases and 1753 controls.

Authors:  Mingqing Xu; Zhicheng Lin
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2010-11-13       Impact factor: 5.067

Review 3.  Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine.

Authors:  Colin N Haile; Thomas R Kosten; Therese A Kosten
Journal:  Am J Drug Alcohol Abuse       Date:  2009       Impact factor: 3.829

4.  Externalizing Problem Behavior in Adolescence: Dopaminergic Genes in Interaction with Peer Acceptance and Rejection.

Authors:  Annelies Janssens; Wim Van Den Noortgate; Luc Goossens; Karine Verschueren; Hilde Colpin; Steven De Laet; Stephan Claes; Karla Van Leeuwen
Journal:  J Youth Adolesc       Date:  2015-05-26

5.  Dopaminergic role in regulating neurophysiological markers of sleep homeostasis in humans.

Authors:  Sebastian C Holst; Alessia Bersagliere; Valérie Bachmann; Wolfgang Berger; Peter Achermann; Hans-Peter Landolt
Journal:  J Neurosci       Date:  2014-01-08       Impact factor: 6.167

6.  Predicting childhood effortful control from interactions between early parenting quality and children's dopamine transporter gene haplotypes.

Authors:  Yi Li; Michael J Sulik; Nancy Eisenberg; Tracy L Spinrad; Kathryn Lemery-Chalfant; Daryn A Stover; Brian C Verrelli
Journal:  Dev Psychopathol       Date:  2015-04-30

7.  SLC6A3 is a risk factor for Parkinson's disease: a meta-analysis of sixteen years' studies.

Authors:  Desheng Zhai; Songji Li; Ying Zhao; Zhicheng Lin
Journal:  Neurosci Lett       Date:  2013-11-07       Impact factor: 3.046

8.  Dopamine transporter (DAT1) VNTR polymorphism in 12 Indian populations.

Authors:  L V K S Bhaskar; Kumarasamy Thangaraj; Connie J Mulligan; Samiksha Wasnik; Amrita Nandan; Varun Kumar Sharma; Vishwas Sharma; Alla Govardhana Reddy; Lalji Singh; Vadlamudi Raghavendra Rao
Journal:  Neurol Sci       Date:  2009-09-25       Impact factor: 3.307

9.  Study of the link between dopamine transporter gene polymorphisms and response to paroxetin and escitalopram in patients with lifelong premature ejaculation.

Authors:  T K Eltonsi; T M Tawfik; L A Rashed; S F GamalEl Din; M A Mahmoud
Journal:  Int J Impot Res       Date:  2017-09-14       Impact factor: 2.896

10.  Dopaminergic Control of Attentional Flexibility: Inhibition of Return is Associated with the Dopamine Transporter Gene (DAT1).

Authors:  Lorenza S Colzato; Jay Pratt; Bernhard Hommel
Journal:  Front Hum Neurosci       Date:  2010-07-13       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.